Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160) [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, tolerability, and pharmacokinetics of the naltrexone implant DLP-160 in opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Naltrexone implant (DLP-160) (Naltrexone)

Snippet

Sponsor: Delpor, Inc. | Conditions: Opiod Use Disorder | Phase 1 | Status: COMPLETED